Ms Louise Mccombie

Affiliate (School of Medicine, Dentistry & Nursing)

email: Louise.Mccombie@glasgow.ac.uk

School of Medicine, Dentistry & Nursing, Royal Infirmary Site

Import to contacts

Publications

List by: Type | Date

Jump to: 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015

Number of items: 20.

2024

Lean, M. E.J. et al. (2024) 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study. Lancet Diabetes and Endocrinology, (doi: 10.1016/S2213-8587(23)00385-6) (Early Online Publication)

2023

Sharma, V., Ricketts, H. C., McCombie, L., Brosnahan, N. , Crawford, L., Slaughter, L., Goodfellow, A., Lean, M. E.J. and Cowan, D. C. (2023) A total diet replacement weight management programme for difficult-to-treat asthma associated with obesity: a randomised controlled feasibility trial. Chest, 163(5), pp. 1026-1037. (doi: 10.1016/j.chest.2023.01.015) (PMID:36649753)

Cassidy, S. et al. (2023) Physical activity, inactivity and sleep during the Diabetes Remission Clinical Trial (DiRECT). Diabetic Medicine, 40(3), e15010. (doi: 10.1111/dme.15010) (PMID:36398460)

Sattar, N. , Welsh, P. , Leslie, W. S., Thom, G. , McCombie, L., Brosnahan, N. , Richardson, J., Gill, J. M. R. , Crawford, L. and Lean, M. E. J. (2023) Dietary weight-management for type 2 diabetes remissions in South Asians: the South Asian diabetes remission randomised trial for proof-of-concept and feasibility (STANDby). Lancet Regional Health – Southeast Asia, 9, 100111. (doi: 10.1016/j.lansea.2022.100111) (PMID:36777452) (PMCID:PMC9904218)

2022

Pugh, J. E. et al. (2022) Increase in colonic PRopionate as a method of prEVENTing weight gain in adults aged 20–40 years (iPREVENT): a multi-centre, double-blind, randomised, parallel-group study to investigate the efficacy of inulin-propionate ester versus inulin (control) in the prevention of weight gain over 12 months. F1000Research, (doi: 10.12688/f1000research.125950.1) (Early Online Publication)

Lean, M. , McCombie, L. and Xin, Y. (2022) Forget polypharmacy for type 2 diabetes! Weight management is a better investment. Nephrology Dialysis Transplantation, 37(5), pp. 844-846. (doi: 10.1093/ndt/gfaa250) (PMID:33263751)

Rehackova, L., Taylor, R., Lean, M. , Barnes, A., McCombie, L., Thom, G. , Brosnahan, N. , Leslie, W. S. and Sniehotta, F. F. (2022) Delivering the Diabetes Remission Clinical Trial (DiRECT) in primary care: experiences of healthcare professionals. Diabetic Medicine, 39(3), e14752. (doi: 10.1111/dme.14752) (PMID:34837259)

Rehackova, L. et al. (2022) Participant experiences in the Diabetes REmission Clinical Trial (DiRECT). Diabetic Medicine, 39(1), e14689. (doi: 10.1111/dme.14689) (PMID:34519099)

2021

Leslie, W. S. et al. (2021) Antihypertensive medication needs and blood pressure control with weight loss in the Diabetes Remission Clinical Trial (DiRECT). Diabetologia, 64(9), pp. 1927-1938. (doi: 10.1007/s00125-021-05471-x) (PMID:34056684)

Thom, G. et al. (2021) Predictors of type 2 diabetes in the Diabetes Remission Clinical Trial (DiRECT). Diabetic Medicine, 38(8), e14395. (doi: 10.1111/dme.14395) (PMID:32870520)

Brosnahan, N. , Leslie, W., McCombie, L., Barnes, A., Thom, G. , McConnachie, A. , Messow, C. M. , Sattar, N. , Taylor, R. and Lean, M. E.J. (2021) Brief formula low‐energy‐diet for relapse management during weight loss maintenance in the Diabetes Remission Clinical Trial (DiRECT). Journal of Human Nutrition and Dietetics, 34(3), pp. 472-479. (doi: 10.1111/jhn.12839) (PMID:33406285)

Thom, G. et al. (2021) Weight loss induced increase in fasting ghrelin concentration is a predictor of weight regain: evidence from the Diabetes Remission Clinical Trial. Diabetes, Obesity and Metabolism, 23(3), pp. 711-719. (doi: 10.1111/dom.14274) (PMID:33369058)

2020

Xin, Y. , Davies, A., Briggs, A. , McCombie, L., Messow, C. M. , Grieve, E. , Leslie, W. S., Taylor, R. and Lean, M. E.J. (2020) Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme. Diabetologia, 63, pp. 2112-2122. (doi: 10.1007/s00125-020-05224-2) (PMID:32776237) (PMCID:PMC7476973)

2019

Lean, M. , McCombie, L. and McSorely, J. (2019) Trends in type 2 diabetes. British Medical Journal, 366, l5407. (doi: 10.1136/bmj.l5407) (PMID:31511237)

McCombie, L., Brosnahan, N. , Ross, H., Bell-Higgs, A., Govan, L. and Lean, M.E.J. (2019) Filling the intervention gap: service evaluation of an intensive nonsurgical weight management programme for severe and complex obesity. Journal of Human Nutrition and Dietetics, 32(3), pp. 329-337. (doi: 10.1111/jhn.12611) (PMID:30565772)

Xin, Y. , Davies, A., McCombie, L., Briggs, A. , Messow, C.-M. , Grieve, E. , Leslie, W. S., Taylor, R. and Lean, M. E.J. (2019) Within-trial cost and 1-year cost-effectiveness of the DiRECT/Counterweight-Plus weight-management programme to achieve remission of type 2 diabetes. Lancet Diabetes and Endocrinology, 7(3), pp. 169-172. (doi: 10.1016/S2213-8587(18)30346-2) (PMID:30581081)

Angelopoulou, K., Leslie, W., McCombie, L., Lean, M. and Hankey, C. (2019) Diabetes and travel insurance costs: let's talk about remission. Practical Diabetes, 36(1), pp. 20-21. (doi: 10.1002/pdi.2205)

2018

McCombie, L. and Grieve, E. (2018) Economic cost of obesity and the cost‐effectiveness of weight management. In: Hankey, C. and Whelan, K. (eds.) Advanced Nutrition and Dietetics in Obesity. John Wiley & Sons, Ltd, pp. 252-259. ISBN 9780470670767 (doi: 10.1002/9781118857991.ch4)

2017

McCombie, L., Leslie, W., Taylor, R., Kennon, B., Sattar, N. and Lean, M. E.J. (2017) Beating type 2 diabetes into remission. British Medical Journal, 358, j4030. (doi: 10.1136/bmj.j4030) (PMID:28903916)

2015

McCombie, L., Lean, M. E.J. and Tigbe, W. W. (2015) Cost-effectiveness of obesity treatment. Medicine, 43(2), pp. 104-107. (doi: 10.1016/j.mpmed.2014.11.007)

This list was generated on Tue Apr 16 08:29:46 2024 BST.

Jump to: Articles | Book Sections